You are here

  • Home
  • Archive
  • Volume 63, Issue 2
  • Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Extended report
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis

Authors

  1. Correspondence to:
    Professor G Steinmann
    Birkendorfer Strasse 65, 88397 Biberach/Riss, Germany; Gerhard.Steinmannbc.boehringer-ingelheim.com
View Full Text

Citation

Alten R, Gromnica-Ihle E, Pohl C, et al
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2004;63:170-176.

Publication history

  • Accepted April 28, 2003
  • First published January 13, 2004.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2004 by Annals of the Rheumatic Diseases